Speaking during the joint unveiling of the report by the Agency, United Nations Office on Drugs, UNODC, and the National Drug Enforcement Agency, (NDLEA) the Acting Director General of NAFDAC, Mrs. Yetunde Oni who was represented by the agency’s Director of Narcotics and Controlled Substances, Dr. Musa Umaru, has said that with the new International Narcotics Control Board, (INCB) report showing disproportionate rise in drug overdoses among females, the National Agency for Food and Drug Administration and Control, NAFDAC, has put in place effective surveillance and monitoring system to ensure availability of controlled substances for medical and scientific purposes while also preventing their diversion. The new report released last week by the INCB had also showed that a total of $1.25 billion illicit drugs are trafficked in West Africa countries, saying that this is being achieved routinely through the issuance of authorization to import/clear, authority to purchase finished narcotics, permit to import and permit to clear as well as continuous surveillance and effective ware house inspection and monitoring”, she said. Oni has said that the narcotic drugs, psychotropic substances and precursors chemicals were controlled within the framework of the three-international drug control convention and are scheduled based on medical utility and potential for abuse. She added that NAFDAC was collaborating with the Federal Ministry of Health, National Drug Law Enforcement Agency (NDLEA) to enhance drug demand reduction activities. The report unveiled in over 100 countries also called for the abolition of death penalty for drug – related offences. It further condemned the extrajudicial targeting of people suspected of illicit drug – related activity, encouraged states to consider alternatives to imprisonment for minor drug – related offences. “The 2016 annual report of the international narcotics control board (INCB) showed disproportionate increase in drug overdoses among women hence the need for gender-sensitive policies and programmes, better health-care access for drug-dependent women and more funding to prevent and treat drug abuse among women.